课题基金基金详情
Gumby在川崎病血管炎症中的作用:调控STAT3的去线性泛素化和炎症信号的活化
结题报告
批准号:
81971477
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
钱光辉
依托单位:
学科分类:
自身免疫性疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
钱光辉
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
川崎病(Kawasaki disease, KD)为全身免疫性血管炎症,是成年后冠心病的高危因素。我们前期研究发现:KD急性期去线性泛素酶Gumby表达下调;敲减Gumby后,p-STAT3和下游炎症基因表达升高;验证Gumby与STAT3有相互作用,且能去除后者线性泛素。据此推测:KD急性期,Gumby可调控STAT3的去线性泛素化、p-STAT3信号活化及其下游炎性基因表达,从而介导KD炎症。故我们拟研究:①KD病例中Gumby、p-STAT3和炎症因子表达量,及其与冠脉损伤的相关性;②冠脉内皮细胞炎性损伤时,Gumby与STAT3相互作用,过表达/敲除前者后,检测STAT3的线性泛素化和活化情况;③鼠KD模型上,Gumby条件敲除后和对照组比较,其KD血管炎症、冠脉损伤、p-STAT3活化及炎症因子表达改变。旨在阐明Gumby调控KD急性期炎症的分子机制,为其防治提供新理论和新靶点。
英文摘要
Kawasaki disease (KD) is a systemic immune vascular inflammation that is a risk factor for coronary heart disease in adulthood. Our previous study found that the expression level of de-linearized ubiquitinase Gumby was down-regulated during the acute phase of KD; both the expression level of p-STAT3 and its downstream inflammatory genes were increased after knockdown of Gumby; the interaction between Gumby and STAT3 was also verified. Furthermore, the Gumby protein can remove linear ubiquitin from STAT3. Accordingly, we speculated that: during the acute phase of KD, Gumby can regulate the disassembly of linear ubiquitin level of STAT3, the activation of p-STAT3 signaling, the relative expression quantity of its downstream inflammatory genes, and eventually involved in the KD inflammatory responses. Therefore, we plan to conduct the following researches:①analyzing the expression level of Gumby, p-STAT3 and inflammatory genes, examining their correlations with coronary artery injury degree of KD samples;②studying the interactions between Gumby and STAT3, after overexpression or knockout of the Gumby gene, then investigating the linear ubiquitin level of STAT3 and also its signaling activation in the coronary endothelial cells with inflammatory injuries;③in the KD models via using the wide-type or gumby gene conditional knockout mouse, investigating and comparing the symptoms of vascular inflammation, the degree of coronary artery injury, the activation of p-STAT3 signaling and also the expression level of its downstream inflammatory genes. Hence this program aims to elucidate the molecular mechanism of Gumby's regulation in acute inflammatory response of KD, and provide new theories and new targets for the prevention and treatment of KD.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
COVID-19大流行期间隔离期间川崎病和并发病原体的临床特征
DOI:10.1007/s12519-021-00431-2
发表时间:2021-06
期刊:World journal of pediatrics : WJP
影响因子:--
作者:Ding YY;Ren Y;Qin J;Qian GH;Tang YJ;Chen Y;Li X;Xu L;Qiao CH;Sun L;Lv HT
通讯作者:Lv HT
DOI:10.1111/febs.16749
发表时间:2023-02
期刊:The FEBS Journal
影响因子:--
作者:Ying Miao;Guang-Hui Qian;Renxia Zhang;Yukang Yuan;Yibo Zuo;Yue-yue Ding;Xuan Li;Yunjia Tang;Huizhen Zheng;H. Lv
通讯作者:Ying Miao;Guang-Hui Qian;Renxia Zhang;Yukang Yuan;Yibo Zuo;Yue-yue Ding;Xuan Li;Yunjia Tang;Huizhen Zheng;H. Lv
Leukocyte proteomics coupled with serum metabolomics identifies novel biomarkers and abnormal amino acid metabolism in Kawasaki disease
白细胞蛋白质组学与血清代谢组学相结合,鉴定出川崎病的新型生物标志物和异常氨基酸代谢
DOI:10.1016/j.jprot.2021.104183
发表时间:2021
期刊:Journal of Proteomics
影响因子:3.3
作者:Qian Guanghui;Xu Lei;Qin Jie;Huang Hongbiao;Zhu Liyan;Tang Yunjia;Li Xuan;Ma Jin;Ma Yingying;Ding Yueyue;Lv Haitao
通讯作者:Lv Haitao
An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities.
参与 I 型干扰素信号传导、宿主防御和抗病毒活性的去泛素化酶的综合观点
DOI:10.3389/fimmu.2021.742542
发表时间:2021
期刊:Frontiers in immunology
影响因子:7.3
作者:Qian G;Zhu L;Li G;Liu Y;Zhang Z;Pan J;Lv H
通讯作者:Lv H
Kawasaki disease: ubiquitin-specific protease 5 promotes endothelial inflammation via TNFα-mediated signaling
川崎病:泛素特异性蛋白酶 5 通过 TNFα 介导的信号传导促进内皮炎症
DOI:10.1038/s41390-022-02341-z
发表时间:2022-11-03
期刊:PEDIATRIC RESEARCH
影响因子:3.6
作者:Huang, Chengcheng;Wang, Wang;Lv, Haitao
通讯作者:Lv, Haitao
自身免疫调节因子APS1去泛素化修饰及其调控巨噬细胞炎症信号活化介导川崎病血管内皮损伤的新机制
  • 批准号:
    82371806
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    钱光辉
  • 依托单位:
靶向去泛素化酶USP5调控冠脉内皮细胞中钙调蛋白受体RAGE信号通路干预川崎病血管炎性损伤的机制和策略研究
  • 批准号:
    82171797
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2021
  • 负责人:
    钱光辉
  • 依托单位:
IFNα诱导ADAR1泛素化降解的机制及其抗病毒效应研究
  • 批准号:
    31600695
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    钱光辉
  • 依托单位:
国内基金
海外基金